Serge Belanger

Stock Analyst at Needham

(4.62)
# 932
Out of 5,144 analysts
990
Total ratings
45.2%
Success rate
10.8%
Average return

Stocks Rated by Serge Belanger

Verrica Pharmaceuticals
Nov 13, 2026
Reiterated: Hold
Price Target: n/a
Current: $3.20
Upside: -
CorMedix
Nov 10, 2026
Reiterated: Buy
Price Target: $15 → $14
Current: $4.82
Upside: +190.46%
Ocular Therapeutix
Nov 10, 2026
Reiterated: Buy
Price Target: $18
Current: $6.01
Upside: +199.50%
Trevi Therapeutics
Nov 10, 2026
Reiterated: Buy
Price Target: $23
Current: $13.29
Upside: +73.06%
Xenon Pharmaceuticals
Nov 10, 2026
Reiterated: Buy
Price Target: $60
Current: $39.26
Upside: +52.83%
Liquidia
Oct 14, 2026
Reiterated: Buy
Price Target: $72 → $58
Current: $56.37
Upside: +2.89%
Pacira BioSciences
Oct 8, 2026
Downgraded: Hold
Price Target: n/a
Current: $36.48
Upside: -
Cytokinetics
Oct 5, 2026
Reiterated: Buy
Price Target: $112
Current: $53.17
Upside: +110.65%
Evommune
Sep 9, 2026
Reiterated: Buy
Price Target: $28
Current: $7.10
Upside: +294.37%
BioCryst Pharmaceuticals
Sep 8, 2026
Reiterated: Buy
Price Target: $16
Current: $7.45
Upside: +114.77%
Reiterated: Hold
Price Target: n/a
Current: $16.68
Upside: -
Reiterated: Buy
Price Target: $164
Current: $128.05
Upside: +28.07%
Reiterated: Hold
Price Target: n/a
Current: $0.2843
Upside: -
Reiterated: Buy
Price Target: $30
Current: $11.73
Upside: +155.75%
Reiterated: Hold
Price Target: $20
Current: $29.17
Upside: -31.44%
Reiterated: Buy
Price Target: $48
Current: $19.46
Upside: +146.66%
Reiterated: Buy
Price Target: $38
Current: $7.63
Upside: +398.03%
Rated: Buy
Price Target: $36 → $40
Current: $27.15
Upside: +47.33%
Reiterated: Buy
Price Target: $56 → $46
Current: $25.43
Upside: +80.89%
Reiterated: Hold
Price Target: n/a
Current: $6.63
Upside: -
Reiterated: Buy
Price Target: $34
Current: $29.80
Upside: +14.09%
Rated: Hold
Price Target: n/a
Current: $0.4486
Upside: n/a
Rated: Hold
Price Target: n/a
Current: $1.19
Upside: n/a
Reiterated: Buy
Price Target: $22
Current: $0.8587
Upside: n/a
Reiterated: Hold
Price Target: n/a
Current: $0.00605
Upside: n/a
Reiterated: Buy
Price Target: $11 → $5
Current: $0.0708
Upside: n/a